Experts are urging the Government to reject the formulation and implementation of policy to fight the Coronavirus (COVID-19) pandemic based solely on the age of the population, as well as calling on both the Government and media organizations to be…
Read More
Supermarket in Denmark charges £4 for one big hand sanitser and £122 for two
Sick of seeing no more loo roll, hand sanitiser, hand wash and the like? Despite needing to be more hygienic than ever, it’s become very difficult to find the right resources during the coronavirus pandemic. So one supermarket in Denmark…
Read More
Researchers propose new method for treating airborne pathogens
The built environment often shapes the spread of disease. Many early cases of COVID-19, the 2019 novel coronavirus, centered on a seafood market in Wuhan City, China. Airports, hospitals and other gathering points can easily become sites of virus transmission….
Read More
Countries groping for best coronavirus response: Expert
Sharon Lewin, director of The Peter Doherty Institute for Infection and Immunity in Melbourne and a top expert on infectious disease policy, spoke with AFP about the unfolding coronavirus pandemic. Countries that got caught off-guard or did not respond to…
Read More
Free coronavirus sequencing kits for researchers offered by U-M startup
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is providing free kits to capture the genetic code of virus samples. Variations in that code reveal how the virus has…
Read More
Potential treatment for Lyme disease kills bacteria that may cause lingering symptoms, study finds
For decades, the routine treatment for Lyme disease has been standard antibiotics, which usually kill off the infection. But for up to 20% of people with the tick-borne illness, the antibiotics don’t work, and lingering symptoms of muscle pain, fatigue…
Read More
Short-Course Rifamycin-Based Regimens Preferred for Latent TB
FRIDAY, Feb. 14, 2020 — For treatment of latent tuberculosis infection (LTBI), short-course rifamycin-based regimens are preferred over longer-course isoniazid monotherapy, according to guidelines published in the Feb. 14 issue of the U.S. Centers for Disease Control and Prevention Morbidity…
Read More
Study finds key mechanism for how typhoid bacteria infects
A new study has uncovered key details for how the Salmonella bacteria that causes typhoid fever identifies a host’s immune cells and delivers toxins that disrupt the immune system and allow the pathogen to spread. The findings, published Feb. 21…
Read More
What’s next for coronavirus, how to avoid it, and will there be a vaccine?
As the new coronavirus, known in shorthand as COVID-19, continues to spread around the world, researchers, including those at the University of Virginia, are turning their attention to developing vaccines and antiviral drugs that could contain and treat the respiratory…
Read More
Injectable drug for faster healing of bone fractures prepares for clinical trials
One in three adults aged 60 and over suffering from a hip fracture dies within one year. Now, a Purdue University-affiliated startup is moving closer to the start of clinical trials for a novel injectable drug that is targeted to…
Read More